Increased lipid peroxidation in sera of ALS patients

Background: Markers of oxidative stress and immune activation are significantly elevated in postmortem ALS CNS tissue, although the relevance to pathogenesis is unclear. Objective: To determine the degree and distribution of oxidative stress and immune activation in living ALS patients and whether these levels correlate with the rate of progression or extent of disease. Method: Serum and CSF samples from sporadic ALS (sALS) patients were assayed for 4-hydroxy-2,3-nonenal (HNE), a lipid peroxidation product, and monocyte chemoattractant protein-1α (MCP-1α), a β-chemokine, by high-performance liquid chromatography and ELISA and compared with levels measured in disease and normal control subjects by one-way analysis of variance. SALS serum levels were analyzed in relation to rate of progression, stage of disease, and drug therapy. Results: HNE levels were significantly elevated in the sera and spinal fluid of sALS patients compared with control populations and positively correlated with extent of disease but not rate of progression. MCP-1α levels were also elevated in the sera of sALS patients, with the exception of the neurodegenerative disease control subjects, but decreased with advancing disease. CSF MCP-1α levels were not different between the sampled populations. There was no correlation between serum HNE and MCP-1α levels in sALS patients and extent of disease. However, an inverse relationship between HNE and MCP-1α was demonstrable in vitro. Low levels of HNE stimulated release of MCP-1α from cultured human macrophages, whereas high levels inhibited release of MCP-1α. Conclusions: These data confirm the presence of increased oxidative stress and immune activation in ALS patients. HNE is also suggested as a possible biomarker of disease.

[1]  T. Siddique,et al.  Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue , 2004, Annals of neurology.

[2]  G. Deuschl,et al.  Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration , 2003, Journal of Neuroimmunology.

[3]  H. Thorlacius,et al.  Allopurinol inhibits CXC chemokine expression and leukocyte adhesion in endotoxemic liver injury , 2003, Inflammation Research.

[4]  L. Nicod,et al.  Superoxide anions induce the maturation of human dendritic cells. , 2003, American journal of respiratory and critical care medicine.

[5]  H. Tohgi,et al.  Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease , 2003, Neuroscience Letters.

[6]  W. T. Thach,et al.  Role of the Posterolateral Cerebellum in Language , 2002, Annals of the New York Academy of Sciences.

[7]  H. Tohgi,et al.  Remarkable increase in the concentration of 8‐hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease , 2002, Journal of neuroscience research.

[8]  M. Mattson,et al.  Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis , 2002, Annals of neurology.

[9]  F. Cipollone,et al.  Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. , 2002, Diabetes care.

[10]  M. Nitti,et al.  Activation of PKC-β isoforms mediates HNE-induced MCP-1 release by macrophages , 2002 .

[11]  D. R. Close,et al.  The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer’s disease , 2002, Neurobiology of Aging.

[12]  B. Liu,et al.  Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration , 2002, Annals of the New York Academy of Sciences.

[13]  B. Halliwell,et al.  Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors , 2001, Brain Research Reviews.

[14]  M. Toborek,et al.  Linoleic acid induces MCP-1 gene expression in human microvascular endothelial cells through an oxidative mechanism. , 2001, The Journal of nutritional biochemistry.

[15]  Wenjie Xie,et al.  Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease , 2001, The Journal of Neuroscience.

[16]  K. Kharbanda,et al.  Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. , 2001, Alcohol.

[17]  D. Attwell,et al.  A chemokine–glutamate connection , 2001, Nature Neuroscience.

[18]  S. Ono,et al.  Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis , 2001, Journal of the Neurological Sciences.

[19]  B. Rollins,et al.  Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[20]  R. Berge,et al.  Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. , 2001, Journal of the American College of Cardiology.

[21]  M. Beal,et al.  Increased oxidative damage to DNA in ALS patients. , 2000, Free radical biology & medicine.

[22]  M. Mattson,et al.  4‐Hydroxynonenal Induces Oxidative Stress and Death of Cultured Spinal Cord Neurons , 2000, Journal of neurochemistry.

[23]  A. Begovich,et al.  T Cell Receptor BV Gene Rearrangements in the Spinal Cords and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis , 1999, Neurobiology of Disease.

[24]  S. Kahlon,et al.  Modulation of monocyte chemokine production and nuclear factor kappa B activity by oxidants. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[25]  T. Montine,et al.  The Lipid Peroxidation Product 4‐Hydroxynonenal Inhibits Neurite Outgrowth, Disrupts Neuronal Microtubules, and Modifies Cellular Tubulin , 1999, Journal of neurochemistry.

[26]  M. Nitti,et al.  Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4‐hydroxy‐2,3‐nonenal: A signaling pathway to modulate vesicular transport of glycoproteins , 1999, Hepatology.

[27]  T. Montine,et al.  4‐Hydroxy‐2(E)‐Nonenal Inhibits CNS Mitochondrial Respiration at Multiple Sites , 1999, Journal of neurochemistry.

[28]  K. Jellinger,et al.  The Role of Iron in Neurodegeneration , 1999, Drugs & aging.

[29]  M. Mattson,et al.  The Lipid Peroxidation Product 4-Hydroxynonenal Impairs Glutamate and Glucose Transport and Choline Acetyltransferase Activity in NSC-19 Motor Neuron Cells , 1999, Experimental Neurology.

[30]  F. V. D. van den Hoogen,et al.  Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures. , 1998, Journal of immunological methods.

[31]  M. Mattson,et al.  Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients , 1998, Annals of neurology.

[32]  M. Mattson,et al.  Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis , 1998, Annals of neurology.

[33]  Gary L. Pattee,et al.  Mitochondria in Sporadic Amyotrophic Lateral Sclerosis , 1998, Experimental Neurology.

[34]  B. Stokes,et al.  Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury , 1998, Journal of neuroscience research.

[35]  M. Selley.  (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. , 1998, Free radical biology & medicine.

[36]  W. Kunz,et al.  Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis , 1998, Journal of the Neurological Sciences.

[37]  J. Niland,et al.  Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases , 1998, Journal of the Neurological Sciences.

[38]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[39]  Robert H. Brown,et al.  Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.

[40]  M. Mattson,et al.  The Lipid Peroxidation Product, 4‐Hydroxy‐2‐trans‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins , 1997, Journal of neurochemistry.

[41]  O. Uchitel,et al.  Evaluation of Antioxidants, Protein, and Lipid Oxidation Products in Blood from Sporadic Amiotrophic Lateral Sclerosis Patients , 1997, Neurochemical Research.

[42]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[43]  V. Bambini,et al.  Amyotrophic lateral sclerosis , 1996, Neurology.

[44]  R. Ransohoff,et al.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.

[45]  R. Fox,et al.  Mechanism of Action of Antimalarial Drugs: Inhibition of Antigen Processing and Presentation , 1993, Lupus.

[46]  P. Mcgeer,et al.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.

[47]  S. Appel,et al.  IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.

[48]  D. Troost,et al.  Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis , 1990, Neuropathology and applied neurobiology.

[49]  P. Kushner,et al.  Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[50]  O. Quehenberger,et al.  Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. , 1989, Arteriosclerosis.

[51]  G. Smith,et al.  A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.

[52]  M. Nitti,et al.  Activation of PKC-beta isoforms mediates HNE-induced MCP-1 release by macrophages. , 2002, Biochemical and biophysical research communications.

[53]  B. Chain,et al.  Reactive oxygen species activate human peripheral blood dendritic cells. , 1999, Free radical biology & medicine.

[54]  H. Przuntek,et al.  Selegiline as immunostimulant--a novel mechanism of action? , 1998, Journal of neural transmission. Supplementum.

[55]  J. Tajti,et al.  Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. , 1993, Archives of neurology.

[56]  K. Cheeseman,et al.  Measuring free radical reactions in vivo. , 1993, British medical bulletin.

[57]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[58]  G. Cecchini,et al.  Possible role of aldehydic lipid peroxidation products as chemoattractants. , 1987, International journal of tissue reactions.